ALB and skin squamous cell carcinoma: <b>Materials and Methods</b>: We conducted a retrospective-observational study at Clinical Center Niš (Serbia) including 35 consecutive clinically N0 high-risk cSCC patients who underwent SLNB using a dual-tracer protocol (<sup>99</sup>mTc-labeled albumin and methylene blue).